Continuous prostaglandin-F 2 infusion for middle-trimester abortion.
Publication
, Journal Article
Lauersen, NH; Wilson, KH
Published in: Lancet
May 26, 1973
Duke Scholars
Published In
Lancet
DOI
ISSN
0140-6736
Publication Date
May 26, 1973
Volume
1
Issue
7813
Start / End Page
1195
Location
England
Related Subject Headings
- Time Factors
- Prostaglandins
- Pregnancy
- Injections
- Humans
- General & Internal Medicine
- Female
- Amnion
- Abortion, Therapeutic
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Lauersen, N. H., & Wilson, K. H. (1973). Continuous prostaglandin-F 2 infusion for middle-trimester abortion. Lancet, 1(7813), 1195. https://doi.org/10.1016/s0140-6736(73)91207-5
Lauersen, N. H., and K. H. Wilson. “Continuous prostaglandin-F 2 infusion for middle-trimester abortion.” Lancet 1, no. 7813 (May 26, 1973): 1195. https://doi.org/10.1016/s0140-6736(73)91207-5.
Lauersen NH, Wilson KH. Continuous prostaglandin-F 2 infusion for middle-trimester abortion. Lancet. 1973 May 26;1(7813):1195.
Lauersen, N. H., and K. H. Wilson. “Continuous prostaglandin-F 2 infusion for middle-trimester abortion.” Lancet, vol. 1, no. 7813, May 1973, p. 1195. Pubmed, doi:10.1016/s0140-6736(73)91207-5.
Lauersen NH, Wilson KH. Continuous prostaglandin-F 2 infusion for middle-trimester abortion. Lancet. 1973 May 26;1(7813):1195.
Published In
Lancet
DOI
ISSN
0140-6736
Publication Date
May 26, 1973
Volume
1
Issue
7813
Start / End Page
1195
Location
England
Related Subject Headings
- Time Factors
- Prostaglandins
- Pregnancy
- Injections
- Humans
- General & Internal Medicine
- Female
- Amnion
- Abortion, Therapeutic
- 11 Medical and Health Sciences